Member since: 2016
Organization: CONTINUUS Pharmaceuticals
Great excipient for sustained release formulations
Application Area: Pharmaceutical formulations
"We've been testing this excipient in sustained release oral formulations and it seems to work very well. More importantly, it is compatible with a broad range of active pharmaceutical ingredients [salts, acids, bases and neutral species]. It comes with a very thorough C of A and Millipore's technical support has been OUTSTANDING!"
Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping.
Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasibility and development to rapid and cost-efficient manufacturing.
Benefits of Parteck® SRP 80:
Manufacturer The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada | Available Worldwide4.7 / 5.0 | 1 reviews